Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Comparison of Anti-HIV Drug Combinations to Prevent Mother-to-Child Transmission of HIV

ClinicalTrials.gov ID: NCT00086359

Public ClinicalTrials.gov record NCT00086359. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 8:20 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III Randomized Trial of the Safety and Antiretroviral Effects of Zidovudine/Lamivudine/Abacavir Versus Zidovudine/Lamivudine/Lopinavir/Ritonavir in the Prevention of Perinatal Transmission of HIV

Study identification

NCT ID
NCT00086359
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Enrollment
19 participants

Conditions and interventions

Conditions

Interventions

  • Abacavir sulfate, lamivudine, and zidovudine Drug
  • Lamivudine/zidovudine Drug
  • Lopinavir/ritonavir Drug

Drug

Eligibility (public fields only)

Age range
13 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2004
Primary completion
Not listed
Completion
Aug 31, 2007
Last update posted
Oct 31, 2021

2004 – 2007

United States locations

U.S. sites
7
U.S. states
6
U.S. cities
7
Facility City State ZIP Site status
Usc La Nichd Crs Los Angeles California 90033
UCSD Mother-Child-Adolescent Program CRS San Diego California 92103
Univ. of Miami Ped. Perinatal HIV/AIDS CRS Miami Florida 33136
Mt. Sinai Hosp. Med. Ctr. - Chicago, Womens & Childrens HIV Program Chicago Illinois 60608
Bronx-Lebanon CRS The Bronx New York 10457
Regional Med. Ctr. at Memphis Memphis Tennessee 38105-2794
Texas Children's Hosp. CRS Houston Texas 77030

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00086359, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 31, 2021 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00086359 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →